An Epidemiologic Study on the Incidence and Significance of HFE Mutations in a Korean Cohort With Nonalcoholic Fatty Liver Disease

Journal of Clinical Gastroenterology

Volumn 44, Issue 7, 2010, Pages e154-e161

  Lee, Sang Hyub ^a   Jeong, Sook Hyang ^a   Lee, Donghun ^b   Lee, Jee Hye ^b   Hwang, Sung Ho ^b   Ae Cho, Young ^b   Park, Young Soo ^b   Hwang, Jin Hyeok ^b   Kim, Jin Wook ^b   Kim, Nayoung ^b   Lee, Dong Ho ^b   Kang, Weechang ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Daejeon University   (South Korea)

Author keywords

HFE gene; Iron; Nonalcoholic fatty liver disease

Indexed keywords

HFE PROTEIN; IRON; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE MUTATION; GROUPS BY AGE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; IRON BLOOD LEVEL; KOREA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS; CASE CONTROL STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; FATTY LIVER; GENETIC PREDISPOSITION; GENETICS; IRON OVERLOAD; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PREVALENCE; RETROSPECTIVE STUDY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON OVERLOAD; KOREA; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PREVALENCE; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 77955175909     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181d347d9     Document Type: Article

References (52)

1. Amarapurkar DN, Hashimoto E, Lesmana LA, et al. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22:788-793.
2. Younossi ZM. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2008;28:2-12.
3. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis. 2001;21:27-41.
4. Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842-845.
5. Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28:370-379.
6. Stremmel W, Karner M, Manzhalii E, et al. Liver and iron metabolism—a comprehensive hypothesis for the pathogenesis of genetic hemochromatosis. Z Gastroenterol. 2007;45:71-75.
7. Valenti L, Dongiovanni P, Fracanzani AL, et al. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Dig Liver Dis. 2003;35:172-178.
8. Nelson JE, Bhattacharya R, Lindor KD, et al. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology. 2007;46:723-729.
9. Yamamoto M, Iwasa M, Iwata K, et al. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2007;22:498-503.
10. Cortez-Pinto H, Jesus L, Barros H, et al. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr. 2006;25:816-823.
11. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007;47:711-717.
12. Valenti L, Fracanzani AL, Dongiovanni P, et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol. 2007;102:1251-1258.
13. Facchini FS, Hua NW, Stoohs RA. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology. 2002;122:931-939.
14. Younossi ZM, Gramlich T, Bacon BR, et al. Hepatic iron and nonalcoholic fatty liver disease. Hepatology. 1999;30:847-850.
15. Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999;30:1356-1362.
16. Neri S, Pulvirenti D, Signorelli S, et al. The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations. Intern Med J. 2008;38:254-358.
17. Bugianesi E, Manzini P, D'Antico S, et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology. 2004;39:179-187.
18. Chitturi S, Weltman M, Farrell GC, et al. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology. 2002;36:142-149.
19. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352:1769-1778.
20. Lin TJ, Lin CL, Wang CS, et al. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan. World J Gastroenterol. 2005;11:3905-3908.
21. Dhillon BK, Das R, Garewal G, et al. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. World J Gastroenterol. 2007;13:2956-2959.
22. Shiono Y, Ikeda R, Hayashi H, et al. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan. Intern Med. 2001;40:852-856.
23. Choi SJ, Min WK, Chun S, et al. Frequencies of C282Y and H63D mutations and transferrin saturation indices in the Korean population. Clin Chem Lab Med. 2002;40:689-692.
24. Mazhar SM, Shiehmorteza M, Sirlin CB. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol. 2009;7:135-140.
25. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis. 2007;11:37-54.
26. Kanazawa M, Yoshiike N, Osaka T, et al. Criteria and classification of obesity in Japan and Asia-Oceania. World Rev Nutr Diet. 2005;94:1-12.
27. Yonal O, Hatirnaz O, Akyuz F, et al. HFE gene mutation, chronic liver disease, and iron overload in Turkey. Dig Dis Sci. 2007;52:3298-3302.
28. Koziol JA, Ho NJ, Felitti VJ, et al. Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene. Clin Chem. 2001;47:1804-1810.
29. Baptista-Gonzalez HA, Rosenfeld-Mann F, Trueba-Gomez R, et al. Association of HFE mutations (C282Y and H63D) with iron overload in blood donors from Mexico City. Ann Hepatol. 2007;6:55-60.
30. Lee SH, Kim JW, Shin SH, et al. HFE gene mutations, serum ferritin level, transferrin saturation, and their clinical correlates in a Korean population. Dig Dis Sci. 2009;54:879-886.
31. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
32. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21:2409-2419.
33. Bonkovsky HL, Jawaid Q, Tortorelli K, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol. 1999;31:421-429.
34. George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology. 1998;114:311-318.
35. Deguti MM, Sipahi AM, Gayotto LC, et al. Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis. Braz J Med Biol Res. 2003;36:739-745.
36. Tomatsu S, Orii KO, Fleming RE, et al. Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis. Proc Natl Acad Sci USA. 2003;100:15788-15793.
37. de Diego C, Opazo S, Murga MJ, et al. H63D homozygotes with hyperferritinaemia: is this genotype, the primary cause of iron overload? Eur J Haematol. 2007;78:66-71.
38. Samarasena J, Winsor W, Lush R, et al. Individuals homozygous for the H63D mutation have significantly elevated iron indexes. Dig Dis Sci. 2006;51:803-807.
39. Njajou OT, Houwing-Duistermaat JJ, Osborne RH, et al. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Eur J Hum Genet. 2003;11:225-231.
40. Gochee PA, Powell LW, Cullen DJ, et al. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology. 2002;122:646-651.
41. Aguilar-Martinez P, Bismuth M, Picot MC, et al. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut. 2001;48:836-842.
42. Ryan E, Byrnes V, Coughlan B, et al. Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration? Gut. 2002;51:108-112.
43. Deugnier Y, Jouanolle AM, Chaperon J, et al. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people. Br J Haematol. 2002;118:1170-1178.
44. Rosen P, Nawroth PP, King G, et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 2001;17:189-212.
45. Bertelsen M, Anggard EE, Carrier MJ. Oxidative stress impairs insulin internalization in endothelial cells in vitro. Diabetologia. 2001;44:605-613.
46. Green A, Basile R, Rumberger JM. Transferrin and iron induce insulin resistance of glucose transport in adipocytes. Metabolism. 2006;55:1042-1045.
47. Fernandez-Real JM, Ricart-Engel W, Arroyo E, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care. 1998;21:62-68.
48. Salonen JT, Tuomainen TP, Nyyssonen K, et al. Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ. 1998;317:727.
49. Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion. Clin Chem. 2005;51:1201-1205.
50. Seltzer CC, Mayer J. Serum iron and iron-binding capacity in adolescents. Ii. Comparison of obese and nonobese subjects. Am J Clin Nutr. 1963;13:354-361.
51. Yanoff LB, Menzie CM, Denkinger BS, et al. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes. 2007;31:1412-1419.
52. Bekri S, Gual P, Anty R, et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. 2006;131:788-796.